Stock overview
Amgen Inc.
Explore the company, reported ownership, price history, and available source evidence.
Amgen develops biotechnology medicines for oncology, inflammation, cardiovascular disease, bone health, and rare diseases.
- Last close
- $414.61
- · AMGN
- Tracked holders
- 2 funds
- Latest available 13F per fund
AMGN · USD
Price
$414.61
+$201.50
(+94.55%)
over selected range
Close · Sep 25, 2026
Market open
1255 stored daily closes
$414.61
Sep 25, 2026
- Range low
- $198.88
- Range high
- $444.12
- Observations
- 1255
- Session date
- Sep 25, 2026
Sep 27, 2021–Sep 25, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Gotham Asset Management largest tracked holder Q2 2026 · filed Aug 14, 2026 · SEC filing | −2% 26'Q2 | $16,875,154 | 0.04% |
|
Thrive Capital
position history
Q2 2026
· filed Aug 14, 2026
· SEC filing 1 SEC filing 2 |
−0% 26'Q2 | $1,621,135 | 0.04% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market